tirzepatide approval canada Eli Lilly cuts price of diabetes, weight-loss drugs in Canada, Globe and Mail reports π GLP-1 Injectable Options in
Description
Mounjaro is not included, because it is approved for type 2 diabetes rather than weight loss
It suppresses glucagon release, reducing the liver glucose output
Additionally, improved glycemic control in diabetic patients reduces overall microvascular complications, potentially creating a more favorable environment for retinal health
Most providers follow a streamlined process that moves from evaluation to delivery in days
#ivtherapy #glp1 #glp1weightloss #tirzepatide #semaglutideforweightloss #weightlossjourney | Hydration Room
No, current clinical trial data and post-marketing surveillance have not identified a direct link between tirzepatide and macular degeneration development or worsening
